SCHEMBL3522804

SCHEMBL3522804

COC(=O)C1=C2c3ccccc3Oc3ccc(Cl)cc3N2CCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.42
DRD2 P14416 2/20 0.42
DRD4 P21917 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
MAPT P10636 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
THPO P40225 1/20 0.41
PMP22 Q01453 1/20 0.41
SLC6A3 Q01959 3/20 0.41
HDAC3 O15379 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
HDAC4 P56524 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3522080 0.88 PGR (0.39) PGRMAPTALDH1A1ALOX15SLC6A3
SCHEMBL3518811 0.84 PGR (0.41) PGRDRD2DRD4CYP1A2CYP3A4
SCHEMBL3521856 0.81 DRD2 (0.41) PGRDRD2DRD4MAPTMEN1
SCHEMBL3520212 0.80 TP53 (0.46) MAPTMEN1KMT2AALDH1A1SLC6A3
SCHEMBL3518712 0.73 PGR (0.41) PGRALDH1A1
SCHEMBL2511903 0.72 CASP3 (0.42) MEN1KMT2AALDH1A1ALOX15SLC6A3
SCHEMBL9886613 0.70 P2RX4 (0.48) MEN1KMT2AALDH1A1SLC6A3
SCHEMBL3521538 0.69 DRD2 (0.49) PGRDRD2DRD4CYP1A2CYP3A4
SCHEMBL962986 0.67 MAPT (0.50) DRD2DRD4CYP1A2CYP3A4CYP2D6
SCHEMBL9949074 0.67 CA12 (0.54) DRD2DRD4CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737136-B2 Non-steroidal progesterone receptor modulators N.V. ORGANON (NL) 2010-06-15 US disclosed
EP-1495030-B1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS ORGANON NV (NL) 2008-08-13 EP disclosed
US-20050171087-A1 Non-steroidal progesterone receptor modulators MERCK SHARP & DOHME B.V. (NL) 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171087-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, PGRMC2 PGR 1/4885DRD2 2299/4885DRD4 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.